Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Quality of critical care publications from the Eastern Mediterranean Region reflected by the sample size, study design, research fields, and journal assessment

From: Evaluating the Published Critical Care Research from the World Health Organization Eastern Mediterranean Region

Country No. Sample size
median (range)
Study design Most common research fieldsa Journal Assessment
RCT
N (%)
NRCT
N (%)
Observational
N (%)
Meta-analysis
N(%)
Review
N(%)
Research field
N (%)
Research field
N (%)
Research field
N (%)
IF Mean (SD) Journals with IF>3
(no)
H Index
Afghanistan 1 410 0 0 1 (100%) 0 0 ID
1 (100%)
N/A N/A 0.37 0 6
Bahrain 11 100 (4–1579) 0 0 9 (81.8%) 0 2 (18.2%) ID
3 (27.3%)
Q/S
3 (27.3%)
Resp
2 (18.2%)
1.31 (1.7) 1 3
Djibouti 2 131 (18–244) 0 0 2 (100%) 0 0 Epidem
1 (50%)
Heme
1 (50%)
N/A 0 0 0
Egypt 165 75 (15–7393) 19 (11.5%) 0 140 (84.8%) 0 6 (3.6%) ID
68 (41.2%)
Resp
24 (14.5%)
Renal
11 (6.7%)
1.34 (1.3) 16 28
Iran 620 84 (4–18,682) 129 (20.8%) 27 (4.4%) 439 (70.8%) 3 (0.48%) 22 (3.5%) ID
132 (21.3%)
Resp
68 (11%)
Cardio
40 (6.5%)
0.54 (1.9) 13 33
Iraq 8 222 (28–986) 0 0 6 (75%) 0 2 (25%) ID
2 (25%)
Q/S
2 (25%)
Burns
2 (25%)
1.32 (0.7) 0 10
Jordan 63 135 (6–10,792) 1 (1.6%) 1 (1.6%) 58 (92.1%) 0 3 (4.8%) ID
14 (22.2%)
Epid
7 (11.1%)
Resp
6 (9.5%)
1.61 (1.6) 6 11
Kuwait 26 94 (5–10,419) 0 0 24 (92.3%) 0 2 (7.7%) ID
15 (57.7%)
Epid
3 (11.5%)
Q/S
2 (7.7%)
1.63 (1.0) 2 17
Lebanon 42 66 (10–1506) 0 3 (7.1%) 32 (76.2%) 0 7 (16.7%) ID
10 (23.8%)
Resp
6 (14.3%)
Burn
5 (12%)
2.00 (2.0) 5 21
Libya 5 423 (260–995) 0 0 5 (100%) 0 0 ID
2 (40%)
Q/S
2 (40%)
Cardio
1 (20%)
0.40 (0.4) 0 1
Morocco 39 145 (9–146) 2 (5.1%) 1 (2.6%) 36 (92.3%) 0 0 ID
9 (23%)
Resp
4 (10.3%)
Q/S
4 (10.3%)
1.9 (2.9) 5 11
Oman 16 65 (29–95) 0 0 15 (93.8%) 0 1 (6.3%) ID
3 (18.8%)
Resp
2 (12.5%)
Epid
2 (12.5%)
0.58 (1.1) 0 10
Pakistan 95 144 (3–5800) 2 (2.1%) 0 89 (93.7%) 0 4 (4.2%) ID
33 (34.7%)
Epid
10 (10.5%)
CV
9 (9.5%)
1.0 (1.2) 5 17
Palestine 5 123 (13–275) 0 0 5 (100%) 0 0 P/F
2 (40%)
ID
2 (40%)
CPR
1 (20%)
1.13 (1.6) 1 2
Qatar 36 201 (36–1036) 1 (2.8%) 0 33 (91.7%) 0 2 (5.6%) ID
4(11%)
Epid
4 (11%)
Org Don
4 (11%)
1.35 (1.1) 1 11
Saudi Arabia 273 130 (6–256,195) 11 (4%) 2 (0.73%) 214 (78.4%) 0 46 (16.9%) ID
78 (28.5%)
Q/S
31 (11.4%)
Resp
23 (8.4%)
1.7 (2.3) 36 40
Sudan 6 99 (85–139) 0 0 6 (100%) 0 0 Epidem
3 (50%)
Resp
2 (33.3%)
Renal
1 (16.7%)
0.36 (1.6) 0 2
Somalia 0 0 0 0 0 0 0 N/A N/A N/A 0 0 0
Syria 3 80b 0 0 2 (66.7%) 0 1 (33.3%) ID
1 (33.3%)
Q/S
1 (33.3%)
Admin
1 (33.3%)
0 0 2
Tunisia 102 101 (6–5872) 6 (5.9%) 1 (0.98%) 90 (88.2%) 3 (2.9%) 2 (1.96%) ID
60 (58.8%)
Resp
13 (12.7%)
Heme
7 (6.9%)
1.9 (2.9) 19 28
United Arab Emirates 16 117 (18–386) 1 (6.25%) 0 12 (75%) 0 3 (18.8%) ID
4 (25%)
Q/S
2 (12.5%)
Trauma
2 (12.5%)
1.46 (1.2) 1 13
Yemen 3 129 (25–387) 0 0 3 (100%) 0 0 Q/S
1 (33.3%)
Education
1 (33.3%)
Cardio
1 (33.3%)
0.47 (0.4) 0 1
  1. IF impact factor, H-index number of h articles that received h citations
  2. a The major research field of articles was classified as: administration (Admin), burn, cardiovascular (CVD), cardio-pulmonary resuscitation (CPR), education, endocrine/nutrition, epidemiology (Epid), ethics/end of life/palliative, gastrointestinal, hematology (Heme), immunology/transplant, infectious diseases (ID), neuroscience, organ donation (Org Don) patient and family support (P/F), pharmacology, professional development, quality and safety (Q/S), renal, respiratory (Resp), surgery, and trauma
  3. bSample size available for only one of the two observational studies